4
Changes in Ownership
FENNEC PHARMACEUTICALS INC. Filed Acc 0001926254-26-000002
Chief Executive Officer acquired 13,710 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hackman Jeffrey S. Chief Executive Officer | 2026-02-18 | Option exercise | +13,710 | 28,710 | D |
Loading xslF345X05/form4-02192026_110240.xml…